$3.18
-0.03[-0.93%]
At close: Apr 19
$3.18
0[0.00%]
After Hours: 5:00PM EDT
Celularity
(NASDAQ:CELU)Celularity Stock (NASDAQ:CELU), Analyst Ratings, Price Targets, Predictions
Celularity Inc has a consensus price target of $4.9, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, HC Wainwright & Co., and Oppenheimer on January 30, 2023, January 30, 2023, and December 22, 2022. With an average price target of $1.17 between Morgan Stanley, HC Wainwright & Co., and Oppenheimer, there's an implied -63.31% downside for Celularity Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
HC Wainwright & Co.
Oppenheimer
Alliance Global Partners
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Celularity
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/30/2023 | CELU | Buy Now | Celularity | $3.18 | -68.55% | Morgan Stanley | Jeffrey Hung | $50 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/30/2023 | CELU | Buy Now | Celularity | $3.18 | -21.38% | HC Wainwright & Co. | Swayampakula Ramakanth | $150 → $25 | Maintains | Buy | Get Alert |
| 12/22/2022 | CELU | Buy Now | Celularity | $3.18 | — | Oppenheimer | Matthew Biegler | — | Downgrade | Outperform → Perform | Get Alert |
| 09/12/2022 | CELU | Buy Now | Celularity | $3.18 | 57.23% | Morgan Stanley | Jeffrey Hung | $80 → $50 | Maintains | Equal-Weight | Get Alert |
| 08/25/2022 | CELU | Buy Now | Celularity | $3.18 | 371.7% | Alliance Global Partners | James Molloy | → $150 | Initiates | → Buy | Get Alert |
| 08/23/2022 | CELU | Buy Now | Celularity | $3.18 | 88.68% | Truist Securities | Asthika Goonewardene | $100 → $60 | Maintains | Hold | Get Alert |
| 06/22/2022 | CELU | Buy Now | Celularity | $3.18 | 371.7% | HC Wainwright & Co. | Swayampakula Ramakanth | → $150 | Initiates | → Buy | Get Alert |
| 04/06/2022 | CELU | Buy Now | Celularity | $3.18 | — | Truist Securities | Asthika Goonewardene | — | Downgrade | Buy → Hold | Get Alert |
| 01/28/2022 | CELU | Buy Now | Celularity | $3.18 | 183.02% | Oppenheimer | Matthew Biegler | → $90 | Initiates | → Outperform | Get Alert |
| 11/24/2021 | CELU | Buy Now | Celularity | $3.18 | 183.02% | Morgan Stanley | Jeffrey Hung | → $90 | Initiates | → Equal-Weight | Get Alert |
| 10/19/2021 | CELU | Buy Now | Celularity | $3.18 | 277.36% | Truist Securities | Asthika Goonewardene | → $120 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Celularity (CELU)?
The latest price target for Celularity (NASDAQ: CELU) was reported by Morgan Stanley on January 30, 2023. The analyst firm set a price target for $1.00 expecting CELU to fall to within 12 months (a possible -68.55% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Celularity (CELU)?
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by Morgan Stanley, and Celularity downgraded their underweight rating.
When was the last upgrade for Celularity (CELU)?
There is no last upgrade for Celularity.
When was the last downgrade for Celularity (CELU)?
The last downgrade for Celularity Inc happened on January 30, 2023 when Morgan Stanley changed their price target from $5 to $1 for Celularity Inc.
When is the next analyst rating going to be posted or updated for Celularity (CELU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
Is the Analyst Rating Celularity (CELU) correct?
While ratings are subjective and will change, the latest Celularity (CELU) rating was a downgraded with a price target of $5.00 to $1.00. The current price Celularity (CELU) is trading at is $3.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.